Detalhe da pesquisa
1.
Risk factors for resistant gram-positive bacteremia in febrile neutropenic patients with cancer.
J Infect Chemother
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38518846
2.
Comparable humoral and cellular immunity against Omicron variant BA.4/5 of once-boosted BA.1/2 convalescents and twice-boosted COVID-19-naïve individuals.
J Med Virol
; 95(2): e28558, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36755360
3.
Tracking antigen-specific TCR clonotypes in SARS-CoV-2 infection reveals distinct severity trajectories.
J Med Virol
; 95(11): e29199, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916645
4.
Effect of Wearing Personal Protective Equipment (PPE) for COVID-19 Treatment on Blood Culture Contamination: Implication for Optimal PPE Strategies.
J Korean Med Sci
; 38(23): e180, 2023 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37309699
5.
Anti-Alpha-Toxin Antibody Responses and Clinical Outcomes of Staphylococcus aureus Bacteremia.
J Korean Med Sci
; 38(16): e129, 2023 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37096312
6.
Persistent Antibody Responses Up to 18 Months After Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis
; 226(7): 1224-1230, 2022 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35299253
7.
Longitudinal Analysis of Memory T-Cell Responses in Survivors of Middle East Respiratory Syndrome.
Clin Infect Dis
; 75(4): 596-603, 2022 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34893799
8.
Evaluation of Seropositivity After Standard Doses of Vaccination Against SARS-CoV-2 in Patients With Early Breast Cancer Receiving Adjuvant Treatment.
Oncologist
; 27(12): e931-e937, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36218350
9.
Accurate Diagnosis of COVID-19 from Self-Collectable Biospecimens Using Synthetic Apolipoprotein H Peptide-Coated Nanoparticle Assay.
Anal Chem
; 94(49): 17186-17194, 2022 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399654
10.
Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection.
BMC Med
; 20(1): 181, 2022 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35508998
11.
Clinical Impact of Empirical Antibiotic Therapy in Patients With Coronavirus Disease 2019 Requiring Oxygen Therapy.
J Korean Med Sci
; 37(29): e238, 2022 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35880508
12.
Kinetics of Neutralizing Antibody Responses Against SARS-CoV-2 Delta Variant in Patients Infected at the Beginning of the Pandemic.
J Korean Med Sci
; 37(8): e67, 2022 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35226425
13.
Breakthrough COVID-19 Infection During the Delta Variant Dominant Period: Individualized Care Based on Vaccination Status Is Needed.
J Korean Med Sci
; 37(32): e252, 2022 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35971766
14.
How We Have Treated Severe to Critically Ill Patients With Coronavirus Disease 2019 in Korea.
J Korean Med Sci
; 37(49): e353, 2022 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36536547
15.
Changes in Anxiety Level and Personal Protective Equipment Use Among Healthcare Workers Exposed to COVID-19.
J Korean Med Sci
; 37(16): e126, 2022 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35470600
16.
Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
J Infect Dis
; 224(1): 39-48, 2021 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33755725
17.
Longitudinal proteomic profiling provides insights into host response and proteome dynamics in COVID-19 progression.
Proteomics
; 21(11-12): e2000278, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33945677
18.
Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability.
Clin Infect Dis
; 73(3): e550-e558, 2021 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32898238
19.
Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019.
Clin Infect Dis
; 73(9): e3002-e3008, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33219681
20.
Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection.
Emerg Infect Dis
; 27(3): 928-931, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33350923